Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manu De Rycker

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Plos One|July 15, 2011
Regulatory domain selectivity in the cell-type specific PKN-dependence of cell migrationSylvie Lachmann, Amy Jevons, Manu De Rycker, et al.
Plos Neglected Tropical Diseases|July 13, 2018
Development of Trypanosoma cruzi in vitro assays to identify compounds suitable for progression in Chagas' disease drug discoveryLorna M MacLean, John Thomas, Michael D Lewis, et al.
Plos One|June 1, 2019
Identification of inhibitors of an unconventional Trypanosoma brucei kinetochore kinaseLeah S Torrie, Fabio Zuccotto, David A Robinson, et al.
Journal of Cell Science|April 4, 2013
ERK2 but not ERK1 mediates HGF-induced motility in non-small cell lung carcinoma cell linesSimone Radtke, Mina Milanovic, Carine Rossé, et al.
Antimicrobial Agents and Chemotherapy|August 14, 2019
<i>Trypanosoma cruzi</i> Phosphomannomutase and Guanosine Diphosphate-Mannose Pyrophosphorylase Ligandability AssessmentFilip Zmuda, Sharon M Shepherd, Michael A J Ferguson, et al.
Nature Communications|May 25, 2026
Trypanosoma cruzi cell atlas as a single-cell resource for understanding parasite population heterogeneity and differentiationRoss F Laidlaw, Marta García-Sánchez, Juliana Da Silva Pacheco, et al.
Plos Neglected Tropical Diseases|September 26, 2015
Development and Validation of a Novel Leishmania donovani Screening Cascade for High-Throughput Screening Using a Novel Axenic Assay with High Predictivity of Leishmanicidal Intracellular ActivityAndrea Nühs, Manu De Rycker, Sujatha Manthri, et al.
Antimicrobial Agents and Chemotherapy|July 17, 2019
Identification of Novel Trypanosoma cruzi Proteasome Inhibitors Using a Luminescence-Based High-Throughput Screening AssayFilip Zmuda, Lalitha Sastry, Sharon M Shepherd, et al.
Communications Biology|July 8, 2025
Identification of potent inhibitors of Leishmania donovani and Leishmania infantum chagasi, the causative agents of Old and New World visceral leishmaniasisBilal Zulfiqar, Fabio Antonio Colombo, Juliana Barbosa Nunes, et al.
Antimicrobial Agents and Chemotherapy|July 17, 2013
The R enantiomer of the antitubercular drug PA-824 as a potential oral treatment for visceral LeishmaniasisStephen Patterson, Susan Wyllie, Laste Stojanovski, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Plos One|July 15, 2011
Regulatory domain selectivity in the cell-type specific PKN-dependence of cell migrationSylvie Lachmann, Amy Jevons, Manu De Rycker, et al.
Plos Neglected Tropical Diseases|July 13, 2018
Development of Trypanosoma cruzi in vitro assays to identify compounds suitable for progression in Chagas' disease drug discoveryLorna M MacLean, John Thomas, Michael D Lewis, et al.
Plos One|June 1, 2019
Identification of inhibitors of an unconventional Trypanosoma brucei kinetochore kinaseLeah S Torrie, Fabio Zuccotto, David A Robinson, et al.
Journal of Cell Science|April 4, 2013
ERK2 but not ERK1 mediates HGF-induced motility in non-small cell lung carcinoma cell linesSimone Radtke, Mina Milanovic, Carine Rossé, et al.
Antimicrobial Agents and Chemotherapy|August 14, 2019
<i>Trypanosoma cruzi</i> Phosphomannomutase and Guanosine Diphosphate-Mannose Pyrophosphorylase Ligandability AssessmentFilip Zmuda, Sharon M Shepherd, Michael A J Ferguson, et al.
Nature Communications|May 25, 2026
Trypanosoma cruzi cell atlas as a single-cell resource for understanding parasite population heterogeneity and differentiationRoss F Laidlaw, Marta García-Sánchez, Juliana Da Silva Pacheco, et al.
Plos Neglected Tropical Diseases|September 26, 2015
Development and Validation of a Novel Leishmania donovani Screening Cascade for High-Throughput Screening Using a Novel Axenic Assay with High Predictivity of Leishmanicidal Intracellular ActivityAndrea Nühs, Manu De Rycker, Sujatha Manthri, et al.
Antimicrobial Agents and Chemotherapy|July 17, 2019
Identification of Novel Trypanosoma cruzi Proteasome Inhibitors Using a Luminescence-Based High-Throughput Screening AssayFilip Zmuda, Lalitha Sastry, Sharon M Shepherd, et al.
Communications Biology|July 8, 2025
Identification of potent inhibitors of Leishmania donovani and Leishmania infantum chagasi, the causative agents of Old and New World visceral leishmaniasisBilal Zulfiqar, Fabio Antonio Colombo, Juliana Barbosa Nunes, et al.
Antimicrobial Agents and Chemotherapy|July 17, 2013
The R enantiomer of the antitubercular drug PA-824 as a potential oral treatment for visceral LeishmaniasisStephen Patterson, Susan Wyllie, Laste Stojanovski, et al.
Pageof 5